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Review Article
Pathophysiology of Cerebral Venous Thrombosis - An overview
Ahmed Itrat , Sana Shoukat, Ayeesha K. Kamal 
Department of Neurology, The Aga Khan University, Karachi.
Abstract
Cerebral venous sinus thrombosis is a disorder with a
unique pathophysiology which needs to be described.A
Medline search of all articles detailing pathophysiology of
CVST was done, using keywords: cerebral venous thrombosis
and pathophysiology. In addition, major texts were reviewed
for additional references. The pathophysiology of CVST
depends on two interconnected events, local signs due to
venous infarct, e.g. hemiparesis and global signs due to raised
ICP from an obstructed venous system - papilloedema and
isolated intracranial hypertension being one of them.
Pathophysiology of CVST is diverse and makes it easier to
understand the diversity of clinical presentations.
Introduction
The advent of modern non-invasive neuro-imaging
techniques has brought into the attention diseases that were
rendered uncommon previously, cerebral venous thrombo-
sis being one of them. Current statistics indicate the estimat-
ed annual incidence to be 3 to 4 cases per 1 million popula-
tion and up to 7 cases per 1 million among children.1 The
skewed ratio of its incidence in women of childbearing age
is mainly because of predisposing factors such as pregnan-
cy, peurperium, and oral contraceptive use. The fact that it
occurs more in the young population differentiates its clini-
cal picture from that of other cerebrovascular pathologies.
This review article aims to reinforce the current concepts on
the pathophysiology of CVT.  
Anatomy
The internal cerebral veins draining blood from the
deep cortical veins empty into the Great Cerebral Vein (of
Galen). The deep and the superficial cortical veins also
drain directly into the great (dural) sinuses via their numer-
ous connections. Blood eventually flows into the internal
jugular vein after draining into the straight sinus. This sup-
ply is extensive enough to provide for collaterals in case of
an occlusion. The superior sagittal and lateral sinuses are
commonly (70%) individually involved by thrombosis. In
30%, both are affected, in addition to cortical and cerebellar
veins.2
Aetiology
Numerous causes have been provided for the devel-
opment of cerebral venous thrombosis, which can be broad-
ly divided into two categories - Infectious causes - which
mainly include migratory involvement of the cavernous
sinus from staphylococcus infection of the face and
Paranasal sinuses, and the Non-infectious causes - in which
systemic conditions such as connective tissue diseases,
other granulomatous or inflammatory disorders and malig-
nancies are most common.2
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Pathophysiology linked to clinical features
Cerebral venous thrombosis refers to complete or
partial occlusion of either the main sinus/sinuses or the
feeding cortical veins leading to secondary effects of vascu-
lar congestion and focal or generalized neurological
deficits. The local effects depend on the site of occlusion. A
major sinus block leads to intracranial hypertension where-
as the deep cortical occlusion would cause localized oede-
ma, venous infarction and petechial haemorrhages. The lat-
ter can merge and become large haematomas, which have a
characteristic appearance on computed tomographic (CT)
scans.1 Since in majority of instances, the deep cortical
veins get involved due to a sinus block, these two scenarios
get overlapped and we see a mixed picture. Isolated
instances of cortical venous thrombosis without sinus
involvement are rare. Formation of thrombi in venous chan-
nels draining the brain is a consequence of the characteris-
tic risk factors under the heading of Virchow's triad, which
includes local trauma to vessel wall, stasis and a hypercoag-
ulable state, the latter being the most important factor in
development of cerebral venous thrombosis. 
Several morphological factors leading to develop-
ment of thrombi in venous channels have been noted. The
striking involvement of superior sagittal sinus in majority of
the cases can be attributed to the fact that the superficial cor-
tical veins draining into it are doing so against the blood
flow in the sinus. This along with the presence of fibrous
septa present at inferior angle of the sinus causes turbulence
hence rendering it more susceptible to thrombosis. A throm-
bosed sagittal sinus leads to compression of the arachnoid
villi, which drain CSF from the ventricles, leading to raised
intracranial pressure and papilloedema.3 However, hydro-
cephalus does not develop as the ventricular communication
with the subarachnoid spaces remains patent. About one
fifth of patients with sinus thrombosis have intracranial
hypertension only, without signs of cortical vein thrombo-
sis.4
Vasogenic oedema, developing due to disruption of
the blood brain barrier and engorgement of the brain inter-
stitium with blood, and cytotoxic oedema resulting from
localized ischaemia and damage to intracellular ion chan-
nels eventually leading to neuronal swelling, is a character-
istic of cerebral venous involvement. Magnetic resonance
imaging (MRI) has shown that both cytotoxic and vaso-
genic oedema occur in cerebral vein thrombosis.5,6  
The outcomes of such a venous drainage compro-
mise can be two- disruption of the blood brain and blood
CSF barrier can lead to haemorrhage and development of
haematomas and secondly,venous  infarction localized to
the area where integrity of the circulation is lost. This out-
come would decide the clinical picture that would follow.  
Hypercoagulable state has been attributed as one of
the major risk factors in the development of CVT.
Mutations in genes encoding for coagulation factors,
increased basal production of these factors in certain physi-
ological and pathological states and certain malignancies
and autoimmune disorders lead to an imbalance between
prothrombic and antithrombotic factors. Mathieu Zuber, in
his study, showed a strong association between mutation of
factor V leiden , a cofactor in the activation of the prothrom-
bin, and the occurrence of CVT and found this mutation to
be the most common coagulation defect in CVT patients.7
In addition, levels of d-dimer, a breakdown product of fib-
rin, have been shown to be a sensitive indicator of the pres-
ence of cerebral sinus thrombosis and normal D dimer lev-
els make the presence of CST very unlikely.8 This is how-
ever, still a subject of much debate.
The association of Pregnancy and puerperium with
cerebral venous thrombosis can be explained by the fact that
there is a state of compensated, accelerated intravascular
coagulation as is necessary for maintenance of the uterine-
placental interface and preparation for the haemostatic chal-
lenge of delivery. This is achieved by a physiological
increase in production of coagulation factors that induce a
prothrombotic state. 
Clinically an arterial and a venous stroke may have
similar presentation as there is great overlap between the
signs and symptoms resulting from neuronal damage, and
compromise of function. This has been noted especially in
the involvement of cortical veins with patent sinuses where
a 'stroke like' episode is seen.9 However, there are differ-
ences that have been noted. A venous stroke usually pres-
ents with an insidious and gradual onset of neurological
deficits and the involvement of the brain does not follow a
major arterial territory. Whereas arterial cerebral ischaemia
usually is a monophasic abrupt thrombotic process and
there is only a small penumbra, CVT is a continuing process
of disequilibrium between prothrombotic and thrombolytic
mechanisms; large areas of the brain are only functionally
or metabolically disturbed but not irreversibly damaged.
Intracranial bleeding in SVT is a consequence of increased
venous and capillary pressure and thus occurs more fre-
quently than in arterial thrombotic disease in which capil-
lary pressure is reduced by the thrombosis and bleeding
occurs during reperfusion of tissue damaged by ischaemia.
This explains the greater incidence of haemorrhagic infarcts
in venous occlusions compared to the arterial ones.
The most frequent symptoms and signs of cerebral
venous thrombosis were found to be headache, focal
seizures with or without secondary generalization, paresis
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(uni- or bilateral) and papilloedema.10 Pseudo tumor cere-
bri, a syndrome many patients of cerebral venous thrombo-
sis present with, develop as a result of increased pressure in
the affected dural sinus. In fact, patients with a pseudo
tumor cerebri syndrome should undergo angiography or
brain MRI before being labeled idiopathic.11
Growth of the thrombus and the good collateraliza-
tion of the venous vessels probably explain the usually grad-
ual onset of symptoms, frequently over weeks and
months.2,12 In contrast to arterial thrombi, spontaneous res-
olution of venous thrombi does occur. This explains the
large number of patients with complete reversibility of their
neurological deficit, as there is a large area of only transient-
ly and reversibly disturbed cerebral tissue.12
Furthermore, mechanisms underlying cerebral
venous thrombosis and deep venous thrombosis of other
areas (e.g. the leg) are probably different. First, cerebral
veins and sinuses have a continuous blood flow and no
valves13, whereas venous flow in the limbs is not continu-
ous but requires the presence of valves and the activity of
muscles. Secondly, the factors that appear to precipitate
deep venous thrombosis including immobilization do not
increase the risk of cerebral venous thrombosis. Moreover,
there is a stronger association of deep venous thrombosis
with cancers than cerebral venous thrombosis.14
Complications and prognostic factors
Parenchymal oedema with venous infarction and
haemorrhage complicate up to 50% of venous sinus throm-
boses.2 Pulmonary embolism , even though encountered
infrequently in patients with cerebral venous thrombosis,
carries a poor prognosis.15 Hypopituitarism may result from
cavernous sinus thrombosis.16 Also, association between
CVT and arteriovenous malformations have been described
in several instances but it is not clearly known which is the
primary event. In a significant number of patients, persist-
ent focal seizures may develop requiring long term anti
epileptic therapies. The main cause of acute death in CVT
patients was found to be neurologic, the most frequent
mechanism being transtentorial herniation.17
Long term prognosis is generally good in these
patients but some factors might contribute to a bad outcome.
These include old age, involvement of deep veins, concomi-
tant CNS infection or cancer, or if the patient presents in
coma or haemorrhage. 
Recent advances in imaging especially Diffusion
weighted Imaging and perfusion Imaging may be helpful in
differentiating arterial from venous stroke. These imaging
techniques not only provide important information regard-
ing pathophysiology but may have a prognostic role.  
Conclusion
CVT has two major manifestations linked to the
pathophysiology, focal, due to cortically based venous
infarction, with seizures, stroke like presentation. The other
scenario is global, with a depressed level of consciousness
and high intracranial pressure due to venous engorgement
and back pressure. These are often intermixed in patients.
Venous infarction, unlike arterial, is often slower in onset,
insidious, often associated with seizures, good recovery of
neurological function in the majority of cases. 
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